Literature DB >> 736030

A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan.

S Miwa, H Fujii, N Matsumoto, T Nakatsuji, S Oda, H Asano, S Asano.   

Abstract

A case of red cell adenosine deaminase (ADA) overproduction associated with hereditary hemolytic anemia is reported here. This appears to be the second report. Proband is a 38-year-old Japanese male who had hemoglobin, 15.8 g/100 ml; reticulocyte count, 4.5%; serum indirect bilirubin, 4.9 mg/100 ml; 51Cr-labeled red cell half-life, 12 days; red cells showed moderate stomatocytosis. His red cell ADA activity showed 40-fold increase while that of the mother showed 4-fold increase. The mother was hematologically normal. The father had a normal enzyme activity. The proband and the mother showed slightly high serum uric acid levels. The proband's red cell showed: ATP, 628 nmoles/ml (normal, 1,010--1,550); adenine nucleotide pool, 46% of the normal mean; 2,3-diphosphoglycerate content, 3,782 nmoles/ml (normal 4,170--5,300); increased oxygen affinity of hemoglobin, P50 of intact erythrocytes being 21.8 mmHg (normal, 24.1--26.1). Red cell glycolytic intermediates in the proband were low in general, and the rate of lactate production was low. Kinetic studies using crude hemolysate revealed a normal Km for adenosine, normal electrophoretic mobility but slightly abnormal pH curve and slightly low utilization of 2-deoxyadenosine. The ADA activity of lymphocytes was nearly normal.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 736030     DOI: 10.1002/ajh.2830050205

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Elevated adenosine deaminase activity and hereditary hemolytic anemia. Evidence for abnormal translational control of protein synthesis.

Authors:  E G Chottiner; H J Cloft; A P Tartaglia; B S Mitchell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

2.  Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

Authors:  M J Cowan; R O Brady; K J Widder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1.

Authors:  Leif S Ludwig; Caleb A Lareau; Erik L Bao; Nan Liu; Taiju Utsugisawa; Alex M Tseng; Samuel A Myers; Jeffrey M Verboon; Jacob C Ulirsch; Wendy Luo; Christoph Muus; Claudia Fiorini; Meagan E Olive; Christopher M Vockley; Mathias Munschauer; Abigail Hunter; Hiromi Ogura; Toshiyuki Yamamoto; Hiroko Inada; Shinichiro Nakagawa; Shuichi Ohzono; Vidya Subramanian; Roberto Chiarle; Bertil Glader; Steven A Carr; Martin J Aryee; Anshul Kundaje; Stuart H Orkin; Aviv Regev; Timothy L McCavit; Hitoshi Kanno; Vijay G Sankaran
Journal:  Blood       Date:  2022-04-21       Impact factor: 25.476

4.  Hereditary overexpression of adenosine deaminase in erythrocytes: evidence for a cis-acting mutation.

Authors:  E H Chen; A P Tartaglia; B S Mitchell
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

Review 5.  Diagnosis of red blood cell enzymopathies in infants, children and adolescents.

Authors:  S P Samuel; T D Miale
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

6.  The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.

Authors:  F Takeuchi; F Hanaoka; E Yano; M Yamada; Y Horiuchi; I Akaoka
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  Molecular cloning of the murine adenosine deaminase gene from a genetically enriched source: identification and characterization of the promoter region.

Authors:  D E Ingolia; M R Al-Ubaidi; C Y Yeung; H A Bigo; D Wright; R E Kellems
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.